An information disclosure statement (often abbreviated as IDS) refers to the submission of relevant background art to the United States Patent and Trademark Office (USPTO) by an applicant for a patent during the patent prosecution process. There is a compulsory on all patent applicants to disclose prior art or background information that may be relevant to the patentability of the applicant’s invention, as established by the United States Code title 35 and related sections of 37 CFR and the Manual of Patent Examining Procedure (MPEP).
With Menteso Information disclosure statement, you get:
Our sophisticated patentability search processes with multilingual capabilities are sure to deliver best-in-class quality search results.
We provide searching of sequences of Proteins, Biomolecules and Nucleic Acids to identify a sequence of interest from a large collection of sequences published worldwide in patent and non-patent documents.
Our team of scientists perform well executed chemical structure searches which include determination of Novelty, Validity and Freedom to Operate.
Our team has vast experience of searching in Japanese, Chinese, Korean, German and Arabic languages.
We provide high quality patent drawings compliant to USPTO, EPO and other patent offices.
We draft provisional and complete patent applications with proper enablement and comprehensive explanation of the invention which are ready to file at USPTO, EPO, IPO, Australia patent office, and WIPO (PCT applications).
Menteso IP Support team offers IDS-related solutions to US patent application filers so that they comply easily with the duty of disclosure.
Our defensive disclosures help corporations in optimizing the IP expenditure and getting the freedom to practice invention without obtaining a patent.
We study thousands of patents of a particular technology to generate the patent landscape analysis report as per the requirement of the client.